18F-FDG PET/CT in Primary Mesothelioma of the Liver

Birgit Pernthaler1, Luka Brcic2, Reingard Maria Aigner1

  • 1From the Division of Nuclear Medicine, Department of Radiology.

Clinical Nuclear Medicine
|December 5, 2022
PubMed

Insights

Primary liver mesothelioma, a rare cancer, was diagnosed in a 48-year-old woman. Imaging (CT, MRI, PET/CT) and histology confirmed this unusual malignant liver tumor.

Area of Science:

  • Oncology
  • Radiology
  • Pathology

Background:

  • Primary malignant mesothelioma of the liver is an exceedingly rare diagnosis.
  • Distinguishing it from secondary liver tumors or other hepatic malignancies poses a diagnostic challenge.

Observation:

  • A 48-year-old woman presented with nonspecific symptoms including abdominal discomfort, inappetence, and significant weight loss.
  • Radiological imaging, including CT and MRI, identified a suspicious liver mass.
  • 18F-FDG PET/CT demonstrated pathological uptake in the liver lesion, aiding in staging.

Findings:

  • Histopathological examination and immunohistochemistry confirmed the diagnosis of primary liver mesothelioma.
  • The case highlights the utility of integrated imaging modalities in diagnosing rare liver tumors.

Implications:

  • This case underscores the importance of considering rare diagnoses in the differential of liver masses.
  • Advanced imaging techniques like PET/CT can be crucial for the accurate staging and characterization of unusual hepatic neoplasms.
  • Further research into the diagnostic and therapeutic strategies for primary liver mesothelioma is warranted.